These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 35989285)

  • 1. Prevalence of SARS-CoV-2 antibodies among university athletic club members: A cross-sectional survey.
    Mori Y; Tanaka M; Kozai H; Hotta K; Aoyama Y; Shigeno Y; Aoike M; Kawamura H; Tsurudome M; Ito M
    Drug Discov Ther; 2022 Sep; 16(4):185-190. PubMed ID: 35989285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population.
    Tilley K; Ayvazyan V; Martinez L; Nanda N; Kawaguchi ES; O'Gorman M; Conti D; Gauderman WJ; Van Orman S
    J Adolesc Health; 2020 Dec; 67(6):763-768. PubMed ID: 33071164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Prevalence of Both Previous Infection with SARS-CoV-2 and Persistent Symptoms.
    Ebell MH; Forgacs D; Shen Y; Ross TM; Hulme C; Bentivegna M; Hanley HB; Jefferson AM; Hainess L
    J Am Board Fam Med; 2022; 35(3):570-578. PubMed ID: 35641057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England.
    Vusirikala A; Whitaker H; Jones S; Tessier E; Borrow R; Linley E; Hoschler K; Baawuah F; Ahmad S; Andrews N; Ramsay M; Ladhani SN; Brown KE; Amirthalingam G
    J Infect; 2021 Jul; 83(1):104-111. PubMed ID: 33933527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Health Care and Hospital Worker SARS-CoV-2 IgG Antibody in a Pediatric Hospital.
    Tokareva Y; Englund JA; Dickerson JA; Brown JC; Zerr DM; Walter E; Tsogoo A; Cappetto K; Valdez Gonzalez J; Strelitz B; Klein EJ
    Hosp Pediatr; 2021 Mar; 11(3):e48-e53. PubMed ID: 33361400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results From Phase I of the Texas Coronavirus Antibody Response Survey.
    Valerio-Shewmaker MA; DeSantis S; Swartz M; Yaseen A; Gonzalez MO; Kohl HWI; Kelder SH; Messiah SE; Aguillard KA; Breaux C; Wu L; Shuford J; Pont S; Lakey D; Boerwinkle E
    Front Public Health; 2021; 9():753487. PubMed ID: 34970525
    [No Abstract]   [Full Text] [Related]  

  • 8. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam.
    Hasan T; Pham TN; Nguyen TA; Le HTT; Van Le D; Dang TT; Van TD; Pham YN; Nguyen HV; Tran GL; Nguyen VTC; Nguyen TT; Truong VQ; Dao TH; Le CT; Truong NT; Vo HT; Le PT; Nguyen TT; Van Luu V; Nguyen VD; Toelle BG; Marks GB; Fox GJ
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34208212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaps in Knowledge About SARS-CoV-2 & COVID-19 Among University Students Are Associated With Negative Attitudes Toward People With COVID-19: A Cross-Sectional Study in Cyprus.
    Middleton N; Tsioutis C; Kolokotroni O; Heraclides A; Theodosis-Nobelos P; Mamais I; Pantelidou M; Tsaltas D; Christaki E; Nikolopoulos G; Dietis N
    Front Public Health; 2021; 9():758030. PubMed ID: 34869173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of SARS-CoV-2 antibodies in the Palestinian population: A primary health center-based cross-sectional study.
    Maraqa B; Basha W; Khayyat R; Abdul-Hadi AR; Jabareen J; Al-Shakhra K; Al-Kaila M; Nazzal Z
    PLoS One; 2021; 16(10):e0258255. PubMed ID: 34624024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.
    Hori H; Fukuchi T; Sanui M; Moriya T; Sugawara H
    PLoS One; 2021; 16(10):e0257513. PubMed ID: 34634076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey.
    Nkuba AN; Makiala SM; Guichet E; Tshiminyi PM; Bazitama YM; Yambayamba MK; Kazenza BM; Kabeya TM; Matungulu EB; Baketana LK; Mitongo NM; Thaurignac G; Leendertz FH; Vanlerberghe V; Pelloquin R; Etard JF; Maman D; Mbala PK; Ayouba A; Peeters M; Muyembe JT; Delaporte E; Ahuka SM
    Clin Infect Dis; 2022 Mar; 74(5):882-890. PubMed ID: 34089598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Screening Using Reverse Transcriptase-Quantitative Polymerase Chain Reaction or CRISPR-Based Assays in Asymptomatic College Students.
    Rauch JN; Valois E; Ponce-Rojas JC; Aralis Z; Lach RS; Zappa F; Audouard M; Solley SC; Vaidya C; Costello M; Smith H; Javanbakht A; Malear B; Polito L; Comer S; Arn K; Kosik KS; Acosta-Alvear D; Wilson MZ; Fitzgibbons L; Arias C
    JAMA Netw Open; 2021 Feb; 4(2):e2037129. PubMed ID: 33570576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of SARS-CoV-2 Test Positivity in NCAA Division I Student Athletes vs Nonathletes at 12 Institutions.
    Schultz EA; Kussman A; Jerome A; Abrams GD; Hwang CE
    JAMA Netw Open; 2022 Feb; 5(2):e2147805. PubMed ID: 35138397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional community-based observational study of asymptomatic SARS-CoV-2 prevalence in the greater Indianapolis area.
    Meyers KJ; Jones ME; Goetz IA; Botros FT; Knorr J; Manner DH; Woodward B
    J Med Virol; 2020 Nov; 92(11):2874-2879. PubMed ID: 32543722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of SARS-CoV-2 Antibodies in Laboratory Healthcare Workers at Assiut University Hospital, Egypt.
    Ezz Eldin AM; Kamal DT; Salah Eldin S; Elkhayat MR; Attia AM; Abd Elhameed ZA
    J Environ Public Health; 2022; 2022():7833623. PubMed ID: 35573077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Intercollegiate Athletics Not Fully Mitigated With Daily Antigen Testing.
    Moreno GK; Braun KM; Pray IW; Segaloff HE; Lim A; Poulsen K; Meiman J; Borcher J; Westergaard RP; Moll MK; Friedrich TC; O'Connor DH
    Clin Infect Dis; 2021 Jul; 73(Suppl 1):S45-S53. PubMed ID: 33977295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time from Start of Quarantine to SARS-CoV-2 Positive Test Among Quarantined College and University Athletes - 17 States, June-October 2020.
    Atherstone C; Peterson ML; Malone M; Honein MA; MacNeil A; O'Neal CS; Paul S; Harmon KG; Goerl K; Wolfe CR; Casani J; Barrios LC;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(1):7-11. PubMed ID: 33417591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers.
    Huynen P; Grégoire C; Gofflot S; Seidel L; Maes N; Vranken L; Delcour S; Moutschen M; Hayette MP; Kolh P; Melin P; Beguin Y
    Sci Rep; 2022 Mar; 12(1):5156. PubMed ID: 35338237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.